Curaleaf Presses Aurora Shareholders to Support Takeover Bid
Curaleaf Holdings (TSE:CURA) urged Aurora Cannabis (ACB) shareholders to accept its takeover offer, valuing shares at a 45% premium. The deal includes cash and Curaleaf stock, aiming to create a global cannabis leader with $1.5B revenue and $350M adjusted EBITDA. Curaleaf cited Aurora's financial challenges and set a December 1, 2026 deadline for shareholder response.
How this was made

The 30-second read
Why it matters
The bid could reshape market share dynamics and set a valuation benchmark for the industry.
Market read
A high‑premium M&A move in the cannabis sector with immediate price implications for both parties.
What to watch
Potential antitrust review and financing of the cash component may strain Curaleaf's balance sheet.
Background
Curaleaf seeks to solidify its leadership by acquiring Aurora, a struggling competitor.
Market effects
Consolidation in the cannabis sector may pressure other midsize growers.
North American cannabis stocks could see increased volatility.
Creates the largest global cannabis entity, influencing worldwide cannabis investment sentiment.
Counterpoint
Deal could face regulatory hurdles or integration challenges, risking value erosion.
Key entities
- ExecutiveBoris Jordan
Chairman and CEO of Curaleaf leading the takeover outreach.





